With the development of biotechnology, certain important biological preparations and pharmaceuticals, which are mainly composed of biological macromolecules, often fail to meet the required purification requirements by using traditional separation and purification techniques (ultrafiltration, precipitation, extraction, and centrifugation, etc.). Therefore, the focus on separation and purification techniques has been shifted to chromatography. In recent years, high-performance liquid chromatography (HPLC) has been at the forefront of contemporary high-performance separation and purification techniques. HPLC is a very important separation and purification technique in organic chemistry and biochemistry. It is divided into normal-phase chromatography and reversed-phase chromatography. Normal-phase chromatography and reversed-phase chromatography can be further divided into adsorption chromatography and polar chemical bonding chromatography. Since polar compounds are more easily retained by polar stationary phases, normal-phase chromatography is generally more suitable for the separation of polar compounds, and reversed-phase chromatography is generally suitable for the separation of non-polar and weakly polar compounds.
Fig.1 DNA and RNA structure. (Wikipedia)
The key technology of this service is HPLC, which utilizes three specialized separation modes: reversed-phase HPLC (separates by hydrophobicity), ion-exchange HPLC (separates by charge), and ion-paired reversed-phase HPLC (enhances resolution for charged molecules), employing various column matrices like silica gel, polymer, and Al2O3 to achieve high-purity DNA and RNA purification.
DNA and RNA are two biomolecules that require high purity for various applications. At CD BioGlyco, we offer HPLC technology for the separation and purification of DNA and RNA to produce higher-purity DNA and RNA. The HPLC process utilizes the "adsorption-elution" principle, and we offer different separation modes for different substances, as shown in Table 1.
Table 1 Sample selection for separation.
| Molecular mass | Solubility / Specificities | Chromatography type | |
| Less than 2000 | Soluble in organic solvents | Soluble in heptane | Silica; Normal-phase chromatography |
| Bonding; Normal-phase chromatography | |||
| Soluble in CH3OH / CH3CN / H2O | Bonding; Reversed-phase chromatography | ||
| Soluble in H2O | Soluble in THF | ||
| GPC | |||
| Unionization | Bonding; Reversed-phase chromatography | ||
| Ionization | |||
| Silica; Normal-phase chromatography | |||
| Ion exchange chromatography | |||
| More than 2000 | Soluble in organic solvents | GPC | |
| Soluble in H2O | GFC | ||
| Ion exchange chromatography | |||
| Macroporous packing; Reversed-phase chromatography | |||
In addition to this, the packing of the column has different effects on the separation of substances, and we offer the main packing materials:
Fig.2 Process of sample isolation and purification. (CD BioGlyco)
Our purification constitutes a rigorously multistage continuum, methodically architected to optimize both immaculate yield and compound restitution. Each step is carefully controlled to ensure the highest quality product is delivered to our clients.
The process begins with a detailed consultation to understand your specific project requirements, including sample type, desired purity, and downstream application. This allows our specialists to tailor the optimal purification strategy, including selecting the appropriate column chemistry and gradient protocol.
Crude, synthesized nucleic acid samples are prepared for injection. This may involve initial desalting to remove small-molecule impurities that can interfere with the HPLC process. Primed specimen thereafter hydrodynamically vectored into chromatographic apparatus, propagated through its propulsive dissolvent flux toward the quiescent adsorptive substrate.
This is the core purification step. As the nucleic acid mixture passes through the HPLC column, molecules interact with the stationary phase based on their physicochemical properties. Using a precisely controlled gradient of solvents, our system separates the full-length target molecules from all impurities, including truncated sequences, unincorporated nucleotides, and other synthesis byproducts. The high-resolution separation allows for the isolation of incredibly pure fractions, even those differing by just a single nucleotide.
Chromatographically liberated molecular cohorts; interrogated by photonic symbionts, then sequestered as discrete consortia. Each fraction is then subjected to rigorous quality control analysis, which includes spectrophotometric quantification and mass spectrometry to verify purity, concentration, and molecular mass. This comprehensive QC provides transparent, reliable data on the final product.
The high-purity fractions are prepared for delivery, typically through lyophilization to a dry powder. The final product is provided with a detailed QC report, including a chromatogram and purity data, ready for immediate use in your critical downstream applications.
DOI.: 10.1016/j.tet.2023.133774
Journal: Tetrahedron
IF: 2.2
Published: 2024
Results: This investigation delineates an unprecedented RP-HPLC purification methodology for oligonucleotides, capitalizing on divergent retention kinetics between target sequences and recalcitrant shortmer contaminants. By substituting conventional acetic anhydride capping with a lipophilic phosphoramidite reagent during solid-phase synthesis, selective 5′-terminal modification of the target oligonucleotide was achieved. This derivatization markedly attenuated its hydrophobicity relative to unmodified failure sequences, thereby enabling single-step fractionation wherein solely the target eluted prematurely from the reversed-phase stationary phase, while impurities exhibited prolonged adsorption. The technique obviates intricate gradient elution protocols and proves particularly efficacious for cholesterol-conjugated oligonucleotides, furnishing an expedient substitute for established HPLC purification regimens that falter with structurally analogous contaminants.
Our DNA and RNA purification provides nucleotide-level precision for applications demanding structural integrity—from CRISPR guide RNAs to ribozyme scaffolds. To harness this precision for functional complexity, we offer De Novo Glycan Display, a platform that engineers cell-surface glycosylation landscapes to direct biological behaviors:
CD BioGlyco is a company with extensive experience in DNA and RNA research. We have professional research equipment for the efficient isolation and purification of DNA and RNA for our clients, and our high-quality service has earned us a good reputation around the world.
Clients can contact our staff directly and we will reply promptly. If you are interested in our services, please feel free to contact us for more details.